Miao et al., 2016 - Google Patents
Oral administration of fermented milk supplemented with synbiotics can influence the physiological condition of Wistar rats in a dose-sensitive and sex-specific mannerMiao et al., 2016
View PDF- Document ID
- 10654127412620562488
- Author
- Miao J
- Lang C
- Kang Z
- Zhu H
- Wang S
- Li M
- Publication year
- Publication venue
- Bioscience of microbiota, food and health
External Links
Snippet
Fermented milk supplemented with two probiotic strains (Bifidobacterium lactis Bi-07 and Lactobacillus acidophilus NCFM) and a prebiotic (isomaltooligosaccharide) was orally administered to Wistar rats for 30 days using three dosages. A commercial yogurt was used …
- 235000015140 cultured milk 0 title abstract description 27
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23Y—INDEXING SCHEME RELATING TO LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23Y2220/00—Lactobacillus
- A23Y2220/73—Rhamnosus
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chong | A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action | |
| Xiao et al. | Lactic acid bacteria in health and disease | |
| Kang et al. | Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats | |
| Sánchez-Moya et al. | In vitro modulation of gut microbiota by whey protein to preserve intestinal health | |
| EP2889371B1 (en) | Bacteroides cect 7771 and the use thereof in the prevention and treatment of excess weight, obesity and metabolic and immunological alterations | |
| Núñez et al. | Evaluation of immune response, microbiota, and blood markers after probiotic bacteria administration in obese mice induced by a high-fat diet | |
| EP2650002A1 (en) | Bifidobacterium cect 7765 and use thereof in the prevention and/or treatment of excess weight, obesity and related pathologies | |
| EP2440217B1 (en) | Nutrition for improving muscle strength in elderly | |
| Mikelsaar et al. | Biodiversity of intestinal lactic acid bacteria in the healthy population | |
| Abbasi et al. | Postbiotics: science, technology and applications | |
| CN102470152A (en) | Lactic acid bacteria and bifidobacteria for treating endotoxemia | |
| EP3182841A1 (en) | Prebiotics for reducing the risk of obesity later in life | |
| Ortiz et al. | Functional dairy products | |
| Wu et al. | A systematic review of the interaction between gut microbiota and host health from a symbiotic perspective | |
| Lin et al. | The Function of Mixed Postbiotic PE0401 in Improving Intestinal Health via Elevating Anti-inflammation, Anti-oxidation, Epithelial Tight Junction Gene Expression and Promoting Beneficial Bacteria Growth. | |
| CN113207961B (en) | Bifidobacterium lactis MN-Gup dairy product and application thereof in improving type 2 diabetes | |
| Miao et al. | Oral administration of fermented milk supplemented with synbiotics can influence the physiological condition of Wistar rats in a dose-sensitive and sex-specific manner | |
| US20220249582A1 (en) | Gaba-producing culturable bacteria and use for improving health | |
| Badkook | Fermented camel milk reduces inflammation in rats fed a high-fat diet | |
| Rackerby et al. | Effects of diet on human gut microbiome and subsequent influence on host physiology and metabolism | |
| Abdisa et al. | Probiotics in health and disease: A review of emerging evidence of potential benefits and harm | |
| Kvit et al. | Role of gut microbiota in lipid metabolism | |
| US20190307802A1 (en) | Probiotic compositions including immune modulators | |
| Ioniță-Radu et al. | Gut microbiota and obesity | |
| Bikheet et al. | The Effect of Two Strains Of LAB (P. acidilactaci and L. lactis) In Laboratory Rats. |